Clinical trial
Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation
NCT01806116 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Soochow University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation
- Lead sponsor
- The First Affiliated Hospital of Soochow University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 30, 2009
- Completion date
- May 31, 2014
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
higher-risk myelodysplastic syndrome, relapsed /refractory acute myeloid leukemia